In this Journal Club, S. K. Singh and R. Singh discuss a study that used bioreactive, tumour microenvironment-modulating nanoparticles with doxorubicin to treat breast tumour xenograft-bearing mice, leading to reversal of immunosuppression and tumour shrinkage.
- Santosh Kumar Singh
- Rajesh Singh